ImmuPharma PLC

IMM

Company Profile

  • Business description

    ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease, and other candidates are P140 CIDP and BioAMB Fungal infections.

  • Contact

    One Bartholomew Close
    LondonEC1A 7BL
    GBR

    T: +44 2072062650

    E: [email protected]

    https://www.immupharma.co.uk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    4

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,660.3022.500.26%
CAC 407,751.8927.83-0.36%
DAX 4023,997.4864.250.27%
Dow JONES (US)42,195.5720.16-0.05%
FTSE 1008,772.3855.930.64%
HKSE23,289.77283.61-1.20%
NASDAQ19,067.41108.46-0.57%
Nikkei 22537,965.10467.88-1.22%
NZX 50 Index12,418.89137.581.12%
S&P 5005,894.0518.12-0.31%
S&P/ASX 2008,434.7024.900.30%
SSE Composite Index3,347.4915.96-0.47%

Market Movers